Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 6
Author(s): Christian C. Felder
Affiliation:
Export Options
About this article
Cite this article as:
Felder C. Christian , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (6) . https://dx.doi.org/10.2174/1570159X1706190423093749
DOI https://dx.doi.org/10.2174/1570159X1706190423093749 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
40
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Pharmacological Effects of Turmeric on Learning, Memory and Expression of Muscarinic Receptor Genes (M1, M3 and M5) in Stress-induced Mouse Model
Current Drug Targets Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Current Neuropharmacology What Does Systems Biology Mean for Drug Development?
Current Medicinal Chemistry Editorial [Hot Topic: Astrocytic Signal Transduction in CNS Disease and Therapy (Guest Editor: Liang Peng)]
Current Signal Transduction Therapy Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Recent Patents on Molecular Cytogenetics
Recent Patents on DNA & Gene Sequences Bifunctional Anti-HIV/TB Inhibitors: Perspective from In-Silico Design and Molecular Dynamics Simulations
Letters in Drug Design & Discovery Application of Chemistry-Based Functional Proteomics to Screening for Novel Drug Targets
Combinatorial Chemistry & High Throughput Screening Editorial: (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze)
Current Pharmaceutical Design Polynuclear Ruthenium, Osmium and Gold Complexes. The Quest for Innovative Anticancer Chemotherapeutics
Current Topics in Medicinal Chemistry Prospect of Individualized Medicine in Chronic Hepatitis C Therapy by Pharmacogenomics
Current Pharmacogenomics Evaluation of Antipsychotic Activity of Ethanolic Extract of Dhatryadi Ghrita on Wistar Rats
Current Psychopharmacology Mycotoxins Levels in Human Milk: A Menace to Infants and Children Health
Current Nutrition & Food Science Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study
CNS & Neurological Disorders - Drug Targets Parkinsons Disease Dementia
Current Psychiatry Reviews Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
Current Pharmaceutical Design Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)
Current Alzheimer Research The Design of G-quadruplex Ligands as Telomerase Inhibitors
Mini-Reviews in Medicinal Chemistry Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases
Current Medicinal Chemistry Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
Current Medicinal Chemistry